BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 13, 2025
See today's BioWorld
Home
» Biopharmaceutical collaborations: January 2020
To read the full story,
subscribe
or
sign in
.
Biopharmaceutical collaborations: January 2020
Feb. 21, 2020
Biopharma licensings, joint ventures and collaborations, including: 4SC, Abbvie, Amgen, Aska, Astellas, Astrazeneca, Bayer, Biogen, Biomed X, Boehringer, Chiesi Farmaceutici, Clinigen, Curis, Cyclica, Daewoong, Daiichi Sankyo, Evotec, Gilead, Hikma, Innovent, Inovio, Ionis, Iovance, Janssen, Mediwound, Merck & Co., Merck KGaA, Mundipharma, Nestle, Novartis, Novo Nordisk, Pfizer, Pharmamar, Phasebio, Probiogen, Roche, Schrodinger, Syndivia, Takeda.
BioWorld
Analysis and data insight